Interestingly, Yamashita et al. reported higher cytotoxic T cells (CD8+) infiltration and PD-1/PD-L1 expression in the MMR-deficient (MMRd) group compared to the MMR-proficient (MMRp) among 149 endometrial cancer patients [37]. This evidence concerns the gene PDCD1 and endometrial cancer.